Procter & Gamble Hygiene and Health Care Ltd's Q4FY18 standalone net profit declines 42.9% yoy to Rs44.6cr

The company’s standalone revenue stood at Rs524.7cr, up 4.3% yoy but down 7.8% qoq.

Aug 23, 2018 03:08 IST India Infoline Research Team

Procter & Gamble Hygiene and Health Care Ltd Q4FY18

Standalone Results Q4FY18: (Rs. in cr)

Q4FY18 YoY (%)
Revenue 524.7 4.3
EBITDA 83.9 [36.0]
EBITDA Margin (%) 16 [1,008]
Net Profit  44.6 [42.9]
***EBITDA margin change is bps
P&G Hygiene & Health Care (PGHH) reported disappointing set of numbers for the quarter. Revenue (net of excise duty for the base quarter) was up marginally by 4.3% yoy to Rs524.7cr. Gross margin for the company improved by 298bps, however same was offset by higher advertisement and other expenses. EBITDA reported steep decline of 36% yoy to Rs83.9cr. EBITDA margin contracted by 10pp yoy to 16%. PAT declined by 42.9% yoy to Rs44.6cr.
  • Advertisement cost increased significantly by 627bps as percent of net sales to 12.9%. This was due to increased investments on product innovations and advertising.
  • Other expenses for the quarter also increased by 524bps yoy as percent of net sales.
  • Depreciation for the quarter was down by 37.3% yoy to Rs12.3cr.
  • Other income stood at Rs6.8cr against Rs10.8cr in same quarter last year.
  • Tax rate for the quarter stood at 40.1% vis-à-vis 33.8% in Q4FY17.
  • Company recommended final dividend of Rs40 per equity share for FY18 (June ending).
 




Technical View:

Procter & Gamble Hygiene and Health Care Ltd ended at Rs. 10,729.95, up by 169.1 points or 1.6% from its previous closing of Rs. 10,560.85 on the BSE.
The scrip opened at Rs. 10,500 and touched a high and low of Rs. 10,733.95 and Rs. 10,476 respectively. A total of 1,993 (NSE+BSE) shares were traded on the counter. The stock traded below its 50 DMA.

Related Story